Ofatumumab use in juvenile systemic lupus erythematosus: A single centre experience

Lupus. 2021 Mar;30(3):527-530. doi: 10.1177/0961203320981137. Epub 2020 Dec 16.

Authors

Ovgu Kul Cinar¹, Matko Marlais², Muthana Al Obaidi¹, Iek Leng Cheng³, Kjell Tullus², Paul Brogan^{1

4}, Elena Moraitis¹

Affiliations

¹ Paediatric Rheumatology Department, Great Ormond Street Hospital for Children NHS Trust, London, UK.
² Paediatric Nephrology Department, Great Ormond Street Hospital for Children NHS Trust, London, UK.
³ Pharmacy, Great Ormond Street Hospital for Children NHS Trust, London, UK.
⁴ Infection, Immunity and Rheumatology Section, Great Ormond Street Institute of Child Health, London, UK.

PMID: 33327846
DOI: 10.1177/0961203320981137

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adolescent
Antibodies, Monoclonal, Humanized / therapeutic use*
Child
Female
Humans
Immunosuppressive Agents / therapeutic use*
Lupus Erythematosus, Systemic / drug therapy*
Retrospective Studies

Substances

Antibodies, Monoclonal, Humanized
Immunosuppressive Agents
ofatumumab